← Leaderboards
Anne Le
Johns Hopkins University
$1,644,216
Attributed
$3,044,881
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $987.2K · FY2013–20$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,044,881 · 3
By mechanism
R01$2,100,998 · 1
S10$561,582 · 1
R21$382,301 · 1
Top collaborators
- Justin S. Hanes5 shared
- Barbara Stauch Slusher5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Hai-Quan Mao$12,355,305
- Chi V. Dang$24,535,395
- Xiao-Fang Yu$15,220,244
- Solomon H Snyder$44,504,082
- Kenneth D. Karlin$16,339,237
Others in their field
Top investigators on “Pancreas”
- David Heimbrook · Leidos Biomedical Research, Inc.$73,277,592
- Jeffrey P Krischer · University Of South Florida$62,791,489
- Klaus H. Kaestner · University Of Pennsylvania$51,057,263
- Anirban Maitra · Johns Hopkins University$43,666,915
- Charles A Coltman · Southwest Oncology Group$36,817,493
- Ali Naji · University Of Pennsylvania$30,540,599
Research focus
PancreasSmall MoleculeIn VivoNovel StrategiesPharmaceutical PreparationsReactive Oxygen SpeciesGlutaminaseInhibitor/AntagonistMalignant NeoplasmsMetabolismPancreatic Cancer CellsPancreatic NeoplasmProductionPrototypeEnzymesCancer CellGlutamineGrowthMalignant Neoplasm Of PancreasCancer TherapyBaseClinicCellsTranslating
Grant awards (8)
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$417,346
R01 · FY2020 · CA
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$406,798
R01 · FY2019 · CA
Thermo-Scientific Q Exactive Plus Orbitrap LC-MS/MS System$561,582
S10 · FY2018 · OD · contact PI
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$425,618
R01 · FY2018 · CA
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$425,618
R01 · FY2017 · CA
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy$425,618
R01 · FY2016 · CA
Profiling Pancreatic Cancer Metabolism and Tumor Microenvironment for Therapy$170,891
R21 · FY2014 · CA · contact PI
Profiling Pancreatic Cancer Metabolism and Tumor Microenvironment for Therapy$211,410
R21 · FY2013 · CA · contact PI